Patent holdings for IPC class G01N 30/50

Total number of patents in this class: 105

10-year publication summary

6
5
9
6
7
4
11
6
3
11
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Shimadzu Corporation
6191
6
Waters Technologies Corporation
1701
6
GE Healthcare Bio-Sciences AB
540
5
Regeneron Pharmaceuticals, Inc.
4323
5
Cytiva Sweden AB
763
4
Bristol-myers Squibb Company
4867
3
JSR Corporation
2525
3
Bio-Rad Laboratories, Inc.
1617
3
Quest Diagnostics Investments LLC
410
3
Repligen Corporation
285
3
Biotage AB
92
2
Genzyme Corporation
1277
2
Global Life Sciences Solutions USA LLC
502
2
Cytiva BioProcess R&D AB
309
2
F. Hoffmann-La Roche AG
7941
1
Hoffmann-La Roche Inc.
3461
1
ExxonMobil Research And Engineering Company
2562
1
Merck Patent GmbH
5824
1
Amgen Inc.
4106
1
Hitachi, Ltd.
15556
1
Other owners 50